Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol Extension for Esophageal Varices in HBV Cirrhosis
NCT05021406Unknown
- Sponsor
- Beijing Friendship Hospital
- Start
- Jan 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of carvedilol in esophageal varices (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: The progression incidence of esophageal varices after 4-year therapy. Status: unknown.
02
Drugs
carvedilol
03
Conditions
esophageal varices
Beyond the preview
Go deeper on NCT05021406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021406.